A Nagoya neurologist discovered he was better at moving research into the world than producing it at the bench. Eight years later, his 11-person company is using ordinary brain scans to tackle an expensive diagnostic bottleneck.
A Johns Hopkins neuroscientist and his CEO brother built a company that reads 169 things out of a single MRI - cognition, temperament, aptitude, risk. From Baltimore, they are betting families will pay to see it.
Omniscient Neurotechnology (o8t) is a Sydney-based brain-mapping company that uses AI and machine learning to turn ordinary MRI scans into detailed maps of the brain's electrical networks, or connectomes. Its flagship FDA-cleared platform, Quicktome, gives neurosurgeons a patient-specific view of the pathways responsible for speech, movement and cognition before they operate, while its research platform, Infinitome, helps scientists study how diseases like Alzheimer's, epilepsy and schizophrenia disrupt brain connectivity. Founded in 2019 and led by CEO Stephen Scheeler, the company has raised roughly US$124 million to date and is expanding connectomics into stroke, movement disorders and brain-computer interfaces.
Springbok Analytics is a Charlottesville, Virginia AI company spun out of the University of Virginia that turns standard 2D MRI scans into precise, interactive 3D maps of the musculoskeletal system. Its FDA-cleared platform quantifies up to ~140 individual muscles - measuring volume, fat infiltration, asymmetry, scar tissue, edema and tendon morphology - to create a 'digital muscle twin' used by elite sports teams, clinical researchers, and longevity programs to assess injury risk, track rehab, and monitor age-related muscle change.